title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna",20220620T092400,https://www.zacks.com/stock/news/1940866/the-zacks-analyst-blog-highlights-lilly-merck-roche-pfizer-and-moderna,MRNA,0.105801,Neutral,-0.007806
"Pharma Stock Roundup: FDA Panel Nod for PFE, MRNA Young Kids' COVID Jabs & More",20220617T123700,https://www.zacks.com/stock/news/1940269/pharma-stock-roundup-fda-panel-nod-for-pfe-mrna-young-kids-covid-jabs-more,MRNA,0.116801,Neutral,-0.027661
"The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK",20220616T140943,https://www.benzinga.com/general/biotech/22/06/27737919/the-daily-biotech-pulse-roches-alzheimers-drug-fails-advisors-back-pfizer-moderna-shots-for-young,MRNA,0.195933,Neutral,0.001107
"The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill",20220318T115038,https://www.benzinga.com/general/biotech/22/03/26197749/the-daily-biotech-pulse-moderna-files-for-2nd-covid-booster-shot-authorization-lexicon-secures-de,MRNA,0.267266,Neutral,-0.00478
Here Are The Companies That Could Profit As Governments Scramble To Secure Monkeypox Treatments And Vaccines,20220528T110000,https://www.forbes.com/sites/roberthart/2022/05/28/here-are-the-companies-that-could-profit-as-governments-scramble-to-secure-monkeypox-treatments-and-vaccines/,MRNA,0.036767,Neutral,0.06245
"Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates",20220518T154100,https://www.zacks.com/stock/news/1926061/biotech-stock-roundup-bbio-up-on-bmy-deal-gild-cmrx-offer-updates,MRNA,0.107351,Neutral,-0.011611
"C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday - C.H. Robinson Worldwide  ( NASDAQ:CHRW ) , Qualcomm  ( NASDAQ:QCOM ) ",20240502T142829,https://www.benzinga.com/news/24/05/38586333/c-h-robinson-worldwide-posts-upbeat-results-joins-avis-budget-group-qualcomm-borgwarner-moderna-and,MRNA,0.124164,Somewhat-Bullish,0.226231
"SAP's Q2 Earnings Decline Y/Y, Revenues Up on Cloud Strength",20220721T153900,https://www.zacks.com/stock/news/1955922/saps-q2-earnings-decline-yy-revenues-up-on-cloud-strength,MRNA,0.032078,Neutral,0.089319
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations - Cardiol Therapeutics  ( NASDAQ:CRDL ) ,20231012T135319,https://www.benzinga.com/general/biotech/23/10/35220787/cardiol-therapeutics-fights-heart-inflammation-with-novel-formulations,MRNA,0.066598,Neutral,-0.014349
"Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback",20231012T122400,https://www.zacks.com/stock/news/2164807/biotech-stock-roundup-bmy-grabs-mrtx-akro-down-on-study-data-alny-faces-setback,MRNA,0.033751,Neutral,0.092178
Aquestive  ( AQST )  to Report Q4 Earnings: Here's What to Expect,20240221T152700,https://www.zacks.com/stock/news/2229443/aquestive-aqst-to-report-q4-earnings-heres-what-to-expect,MRNA,0.277118,Neutral,-0.094156
"The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact",20220518T141510,https://www.benzinga.com/general/biotech/22/05/27274688/the-daily-biotech-pulse-pfizerbiontechs-covid-19-booster-for-kids-5-11-years-moderna-starts-first,MRNA,0.118676,Neutral,0.022292
"Stocks making the biggest moves midday: GameStop, Tesla, FedEx and more",20220318T163340,https://www.cnbc.com/2022/03/18/stocks-making-the-biggest-moves-midday-gamestop-tesla-and-more.html,MRNA,0.172589,Neutral,0.001449
Recap Of Friday's Biotech Catalysts - End Of The Day Summary,20220722T215911,https://www.benzinga.com/general/biotech/22/07/28176253/recap-of-fridays-biotech-catalysts-end-of-the-day-summary,MRNA,0.138464,Neutral,0.102997
"Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday - Moderna  ( NASDAQ:MRNA ) , Surgery Partners  ( NASDAQ:SGRY ) , Kosmos Energy  ( NYSE:KOS ) ",20240226T161856,https://www.benzinga.com/news/24/02/37315271/surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-m,MRNA,0.250386,Neutral,-0.147622
"MRNA: Which of These 3 Biotech Stocks Are a Buy, Sell, or Hold?",20230901T174349,https://stocknews.com/news/mrna-fold-mgnx-mrk-incy-which-of-these-3-biotech-stocks-are-a-buy-sell/,MRNA,0.230509,Neutral,0.124273
"Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday - Amprius Technologies  ( NYSE:AMPX ) , ALFI  ( NASDAQ:ALF ) ",20221024T093702,https://www.benzinga.com/news/22/10/29374553/why-huntington-bancshares-shares-surged-around-10-here-are-72-biggest-movers-from-friday,MRNA,0.062761,Neutral,0.100038
"DEADLINE ALERT for BMBL, MGX, POWW, FNA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Bumble  ( NASDAQ:BMBL ) ",20241125T193136,https://www.benzinga.com/pressreleases/24/11/g42172931/deadline-alert-for-bmbl-mgx-poww-fna-law-offices-of-howard-g-smith-reminds-investors-of-class-acti,MRNA,0.054483,Neutral,-0.066129
"DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241114T171000,https://www.benzinga.com/pressreleases/24/11/g41980990/deadline-alert-for-mgx-poww-and-fna-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-act,MRNA,0.086556,Neutral,-0.083249
"DEADLINE ALERT for BMBL, MGX, POWW, FNA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Bumble  ( NASDAQ:BMBL ) ",20241107T021821,https://www.benzinga.com/pressreleases/24/11/g41794972/deadline-alert-for-bmbl-mgx-poww-fna-law-offices-of-howard-g-smith-reminds-investors-of-class-acti,MRNA,0.054483,Neutral,-0.066129
"DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241105T173600,https://www.benzinga.com/pressreleases/24/11/g41752894/deadline-alert-for-mgx-poww-and-fna-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-act,MRNA,0.086556,Neutral,-0.083249
"DEADLINE ALERT for BMBL, MGX, POWW, FNA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders",20241031T220952,https://www.benzinga.com/pressreleases/24/10/g41667213/deadline-alert-for-bmbl-mgx-poww-fna-law-offices-of-howard-g-smith-reminds-investors-of-class-acti,MRNA,0.054483,Neutral,-0.066129
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AMMO, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241030T010000,https://www.benzinga.com/pressreleases/24/10/g41615483/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-ammo-,MRNA,0.079921,Neutral,0.027206
"DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241029T160700,https://www.benzinga.com/pressreleases/24/10/g41604803/deadline-alert-for-mgx-poww-and-fna-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-act,MRNA,0.086556,Neutral,-0.083249
"DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241018T161300,https://www.benzinga.com/pressreleases/24/10/g41406075/deadline-alert-for-mgx-poww-and-fna-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-act,MRNA,0.086556,Neutral,-0.083249
"DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241011T160900,https://www.benzinga.com/pressreleases/24/10/g41294789/deadline-alert-for-mgx-poww-and-fna-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-act,MRNA,0.086556,Neutral,-0.083249
"DEADLINE ALERT for MGX, POWW, and FNA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Paragon 28  ( NYSE:FNA ) , Metagenomi  ( NASDAQ:MGX ) ",20241004T160900,https://www.benzinga.com/pressreleases/24/10/g41188426/deadline-alert-for-mgx-poww-and-fna-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-act,MRNA,0.086556,Neutral,-0.083249
Jim Cramer Says He Is Not Recommending This Group Of Stocks: 'They Don't Make Anybody Any Money',20220819T120731,https://www.benzinga.com/news/22/08/28562296/jim-cramer-says-he-is-not-recommending-this-group-of-stocks-they-dont-make-anybody-any-money,MRNA,0.481177,Bullish,0.554926
Cramer's lightning round: Paramount is worth the house of pain,20220818T232522,https://www.cnbc.com/2022/08/18/cramers-lightning-round-paramount-is-worth-the-house-of-pain.html,MRNA,0.395012,Neutral,0.0
Biotech Plummets On 'Watershed Moment' For Its Field,20240702T125300,https://www.investors.com/news/technology/biotech-stock-cartesian-therapeutics-car-t-generalized-myasthenia-gravis/,MRNA,0.165031,Bullish,0.45849
Bearishness in stocks sets in as positive seasonal factors did little to lift the market,20230105T170200,https://www.marketwatch.com/story/bearishness-in-stocks-sets-in-as-positive-seasonal-factors-did-little-to-lift-the-market-11672938152,MRNA,0.050148,Neutral,0.050521
"Stocks making the biggest moves midday: Gilead Sciences, Moderna, Tesla and more",20221220T173631,https://www.cnbc.com/2022/12/20/stocks-making-the-biggest-moves-midday-gilead-sciences-moderna-tesla-and-more.html,MRNA,0.073321,Somewhat-Bullish,0.178158
"Company News for Jul 7, 2023",20230707T125600,https://www.zacks.com/stock/news/2117987/company-news-for-jul-7-2023,MRNA,0.576289,Somewhat-Bullish,0.248912
"Stocks making the biggest moves midday: JetBlue, Affirm, Genius Sports, Sweetgreen and more",20230706T165854,https://www.cnbc.com/2023/07/06/stocks-making-the-biggest-moves-midday-.html,MRNA,0.212115,Neutral,-0.038961
"BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday - Archer Aviation  ( NYSE:ACHR ) , BridgeBio Pharma  ( NASDAQ:BBIO ) ",20241125T152128,https://www.benzinga.com/24/11/42166800/bridgebio-pharma-rigetti-computing-bath-body-works-and-other-big-stocks-moving-higher-on-monday,MRNA,0.181819,Neutral,0.0
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm - Cognyte Software  ( NASDAQ:CGNT ) , Catalent  ( NYSE:CTLT ) ",20230418T010000,https://www.benzinga.com/pressreleases/23/04/g31845057/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,MRNA,0.011195,Neutral,0.030451
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm - Cognyte Software  ( NASDAQ:CGNT ) , Catalent  ( NYSE:CTLT ) ",20230328T010000,https://www.benzinga.com/pressreleases/23/03/g31522689/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,MRNA,0.01119,Neutral,0.03045
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Catalent, Tesla, DLocal, and Cognyte and Encourages Investors to Contact the Firm - Cognyte Software  ( NASDAQ:CGNT ) , Catalent  ( NYSE:CTLT ) ",20230318T010000,https://www.benzinga.com/pressreleases/23/03/g31408388/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-catal,MRNA,0.01119,Neutral,0.03045
Nasdaq Surges Over 300 Points; Moderna Earnings Beat Expectations,20220803T183340,https://www.benzinga.com/news/earnings/22/08/28338722/nasdaq-surges-over-300-points-moderna-earnings-beat-expectations,MRNA,0.17179,Neutral,0.004386
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,MRNA,0.098659,Neutral,0.0
66 Biggest Movers From Yesterday,20220503T100824,https://www.benzinga.com/news/22/05/26954454/66-biggest-movers-from-yesterday,MRNA,0.056748,Neutral,0.001635
"Job Cuts Today, What Tomorrow? Big Tech Faces Some Big Tests.",20230124T113100,https://www.barrons.com/amp/articles/what-to-know-today-51674547396,MRNA,0.04303,Neutral,0.068639
"Dow Jumps 700 Points; S&P 500 Rises Over 2% - Aehr Test Systems  ( NASDAQ:AEHR ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",20230106T194324,https://www.benzinga.com/news/earnings/23/01/30316154/dow-jumps-700-points-s-p-500-rises-over-2,MRNA,0.05257,Somewhat-Bullish,0.181645
"Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge - Aehr Test Systems  ( NASDAQ:AEHR ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ",20230106T170106,https://www.benzinga.com/news/earnings/23/01/30313745/nasdaq-gains-1-5-fate-therapeutics-shares-plunge,MRNA,0.053153,Somewhat-Bullish,0.181717
"Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket - ABVC BioPharma  ( NASDAQ:ABVC ) , Acasti Pharma  ( NASDAQ:ACST ) ",20230106T130036,https://www.benzinga.com/news/23/01/30309039/why-graphite-bio-shares-are-trading-lower-by-50-here-are-20-stocks-moving-premarket,MRNA,0.063763,Neutral,0.0
"The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study",20220607T123117,https://www.benzinga.com/general/biotech/22/06/27583701/the-daily-biotech-pulse-veru-seeks-emergency-use-nod-for-covid-19-therapy-vincerx-cuts-workforce-,MRNA,0.10322,Neutral,0.025429
"Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday - Alcoa  ( NYSE:AA ) , Alector  ( NASDAQ:ALEC ) ",20231214T151520,https://www.benzinga.com/news/23/12/36239155/jabil-posts-upbeat-earnings-joins-moderna-rivian-automotive-and-other-big-stocks-moving-higher-on-th,MRNA,0.290033,Neutral,0.076997
"Moderna, Amazon, Tesla, And Other Big Gainers From Friday - Atara Biotherapeutics  ( NASDAQ:ATRA ) , Amazon.com  ( NASDAQ:AMZN ) ",20221024T081911,https://www.benzinga.com/news/22/10/29372471/moderna-amazon-tesla-and-other-big-gainers-from-friday,MRNA,0.179788,Neutral,0.142929
"Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday - AZZ  ( NYSE:AZZ ) , BioNTech  ( NASDAQ:BNTX ) ",20221012T142846,https://www.benzinga.com/news/22/10/29237483/moderna-biontech-and-some-other-big-stocks-moving-higher-on-wednesday,MRNA,0.481177,Neutral,0.01262
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped - ARK Fintech Innovation ETF  ( ARCA:ARKF ) ,20241107T024506,https://www.benzinga.com/markets/equities/24/11/41795194/cathie-woods-wednesday-exodus-moderna-and-jack-dorseys-block-stocks-get-dumped,MRNA,0.704675,Bullish,0.382437
This Week's 5-Stock Rate Cut Watchlist,20240916T115617,https://moneymorning.com/2024/09/16/this-weeks-5-stock-rate-cut-watchlist/,MRNA,0.100729,Neutral,-0.123648
"Tesla, Alphabet, SoFi, Paramount, Apple, Domino's, and More Stock Market Movers",20240429T082800,https://www.barrons.com/amp/articles/stock-market-movers-4c54f840,MRNA,0.06515,Neutral,-0.057048
"Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",20240429T055121,https://www.benzinga.com/news/earnings/24/04/38481553/will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports,MRNA,0.069294,Neutral,0.0
96 Biggest Movers From Yesterday,20220315T085138,https://www.benzinga.com/news/22/03/26136650/96-biggest-movers-from-yesterday,MRNA,0.046412,Neutral,0.021621
96 Biggest Movers From Yesterday,20220315T085138,https://markets.businessinsider.com/news/stocks/96-biggest-movers-from-yesterday-1031280260,MRNA,0.023638,Neutral,0.024401
Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek,20241223T184400,https://www.zacks.com/stock/news/2387103/vertex-secures-fda-approval-for-new-cystic-fibrosis-drug-alyftrek,MRNA,0.165788,Neutral,-0.149455
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20241127T130000,https://www.benzinga.com/pressreleases/24/11/g42212288/cytomx-therapeutics-to-present-at-the-36th-annual-piper-sandler-healthcare-conference,MRNA,0.087824,Neutral,0.041182
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference,20241127T130000,https://www.globenewswire.com/news-release/2024/11/27/2988176/37704/en/CytomX-Therapeutics-to-Present-at-the-36th-Annual-Piper-Sandler-Healthcare-Conference.html,MRNA,0.10607,Neutral,0.047068
"CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 - CytomX Therapeutics  ( NASDAQ:CTMX ) ",20241031T120000,https://www.benzinga.com/pressreleases/24/10/g41650384/cytomx-therapeutics-to-report-third-quarter-2024-financial-results-on-november-7-2024,MRNA,0.089462,Neutral,0.048799
"CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors",20240909T120000,https://www.globenewswire.com/news-release/2024/09/09/2942754/37704/en/CytomX-Therapeutics-Announces-First-Patient-Dosed-with-CX-801-a-Dually-Masked-Interferon-Alpha-2b-PROBODY-in-a-Phase-1-Study-in-Patients-with-Solid-Tumors.html,MRNA,0.039483,Neutral,0.047495
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference,20240618T120000,https://www.globenewswire.com/news-release/2024/06/18/2900339/37704/en/CytomX-Therapeutics-to-Present-at-the-H-C-Wainwright-2nd-Annual-Immune-Cell-Engager-Virtual-Conference.html,MRNA,0.109956,Neutral,0.055734
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20240617T201500,https://www.benzinga.com/pressreleases/24/06/g39366109/cytomx-therapeutics-promotes-chris-ogden-to-chief-financial-officer,MRNA,0.034087,Neutral,0.04386
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer,20240617T201500,https://www.globenewswire.com/news-release/2024/06/17/2900015/37704/en/CytomX-Therapeutics-Promotes-Chris-Ogden-to-Chief-Financial-Officer.html,MRNA,0.036091,Neutral,0.046131
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference,20240522T200500,https://www.globenewswire.com/news-release/2024/05/22/2886834/37704/en/CytomX-Therapeutics-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html,MRNA,0.113597,Neutral,0.056493
CytomX Therapeutics Announces New Employment Inducement Grants,20240516T201500,https://www.globenewswire.com/news-release/2024/05/16/2883880/37704/en/CytomX-Therapeutics-Announces-New-Employment-Inducement-Grants.html,MRNA,0.098255,Neutral,0.051259
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20240508T201000,https://www.benzinga.com/pressreleases/24/05/g38712713/cytomx-therapeutics-reports-first-quarter-2024-financial-results-and-provides-business-update,MRNA,0.061512,Neutral,0.078222
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA®  ( pembrolizumab ) ,20240507T201500,https://www.globenewswire.com/news-release/2024/05/07/2877258/37704/en/CytomX-Therapeutics-Announces-Clinical-Collaboration-with-Merck-to-Evaluate-CX-801-in-Combination-with-KEYTRUDA-pembrolizumab.html,MRNA,0.032961,Neutral,0.046708
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific  ( TCB )  Collaboration with Astellas,20240403T120000,https://www.globenewswire.com/news-release/2024/04/03/2856845/37704/en/CytomX-Therapeutics-Announces-Nomination-of-Second-Clinical-Candidate-in-Broad-PROBODY-T-Cell-Engaging-Bispecific-TCB-Collaboration-with-Astellas.html,MRNA,0.039811,Neutral,0.04956
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20240311T201000,https://www.benzinga.com/pressreleases/24/03/g37598795/cytomx-therapeutics-reports-2023-financial-results-and-provides-business-update,MRNA,0.095075,Neutral,0.053096
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update,20240311T201000,https://www.globenewswire.com/news-release/2024/03/11/2844158/37704/en/CytomX-Therapeutics-Reports-2023-Financial-Results-and-Provides-Business-Update.html,MRNA,0.09539,Neutral,0.042567
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20240112T130000,https://www.benzinga.com/pressreleases/24/01/g36609305/cytomx-therapeutics-to-present-at-the-b-riley-securities-virtual-annual-oncology-conference,MRNA,0.095138,Neutral,0.022799
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference,20240112T130000,https://www.globenewswire.com/news-release/2024/01/12/2808578/37704/en/CytomX-Therapeutics-to-Present-at-the-B-Riley-Securities-Virtual-Annual-Oncology-Conference.html,MRNA,0.105604,Neutral,0.024792
"Moderna  ( MRNA )  Issues 2023 Preliminary Results, Stock Up 4%",20240109T181500,https://www.zacks.com/stock/news/2207654/moderna-mrna-issues-2023-preliminary-results-stock-up-4,MRNA,0.64962,Somewhat-Bullish,0.15185
CytomX Therapeutics Outlines 2024 Company Priorities and Milestones - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20240104T130000,https://www.benzinga.com/pressreleases/24/01/g36488030/cytomx-therapeutics-outlines-2024-company-priorities-and-milestones,MRNA,0.072655,Neutral,0.046793
CytomX Therapeutics Outlines 2024 Company Priorities and Milestones,20240104T130000,https://www.globenewswire.com/news-release/2024/01/04/2803919/37704/en/CytomX-Therapeutics-Outlines-2024-Company-Priorities-and-Milestones.html,MRNA,0.074518,Neutral,0.045805
Why Moderna  ( MRNA )  Stock Price Was Up 13% on Tuesday,20240103T185600,https://www.zacks.com/stock/news/2205244/why-moderna-mrna-stock-price-was-up-13-on-tuesday,MRNA,0.570165,Somewhat-Bullish,0.270732
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference,20231221T130000,https://www.globenewswire.com/news-release/2023/12/21/2799945/37704/en/CytomX-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html,MRNA,0.101582,Neutral,-0.02539
CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20231221T130000,https://www.benzinga.com/pressreleases/23/12/g36341721/cytomx-therapeutics-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference,MRNA,0.09402,Neutral,-0.023668
"Moderna  ( MRNA ) , Merck Start 2nd Late-Study on Cancer Therapy",20231212T181700,https://www.zacks.com/stock/news/2196987/moderna-mrna-merck-start-2nd-late-study-on-cancer-therapy,MRNA,0.546745,Neutral,0.030291
GSK: 3 Pharma Stocks on the Rise - It's Time to Buy Now,20231128T164445,https://stocknews.com/news/gsk-eton-ctmx-arwr-srra-3-pharma-stocks-on-the-rise-its-time-to/,MRNA,0.024597,Neutral,0.082215
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update,20231107T211500,https://www.globenewswire.com/news-release/2023/11/07/2775653/37704/en/CytomX-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html,MRNA,0.089729,Neutral,0.013733
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20231107T211500,https://www.benzinga.com/pressreleases/23/11/g35658764/cytomx-therapeutics-reports-third-quarter-2023-financial-results-and-provides-business-update,MRNA,0.087503,Neutral,0.040952
CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20231030T120000,https://www.benzinga.com/pressreleases/23/10/g35487786/cytomx-therapeutics-to-present-preclinical-data-for-conditionally-activated-interferon-alpha-2b-at,MRNA,0.043579,Neutral,-0.008973
CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference,20231018T203000,https://www.globenewswire.com/news-release/2023/10/18/2762767/37704/en/CytomX-Therapeutics-Presents-Preclinical-Profile-of-EpCAM-directed-Antibody-Drug-Conjugate-CX-2051-at-2023-World-ADC-Conference.html,MRNA,0.036926,Neutral,-0.00888
CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20230810T200500,https://www.benzinga.com/pressreleases/23/08/g33723142/cytomx-therapeutics-to-present-at-the-h-c-wainwright-immune-cell-engager-virtual-conference,MRNA,0.092569,Neutral,-0.001079
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update,20230808T201500,https://www.globenewswire.com/news-release/2023/08/08/2721181/37704/en/CytomX-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html,MRNA,0.05383,Neutral,0.043999
Why Is CytomX Therapeutics  ( CTMX )  Stock Shooting Higher Today - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20230630T152637,https://www.benzinga.com/markets/equities/23/06/33079372/why-is-cytomx-therapeutics-stock-shooting-higher-today,MRNA,0.139265,Neutral,0.110653
Why CytomX Therapeutics  ( CTMX )  Shares Are Falling Today - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20230328T153514,https://www.benzinga.com/general/biotech/23/03/31531824/abbvie-walks-away-from-cytomx-partnership-but-garnering-attention-of-big-pharma-partners,MRNA,0.140896,Somewhat-Bullish,0.161862
CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update,20230327T201500,https://www.globenewswire.com/news-release/2023/03/27/2635245/37704/en/CytomX-Therapeutics-Reports-Full-Year-2022-Financial-Results-and-Provides-Business-Update.html,MRNA,0.126284,Neutral,0.05576
"CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023 - CytomX Therapeutics  ( NASDAQ:CTMX ) ",20230322T232333,https://www.benzinga.com/pressreleases/23/03/g31466980/cytomx-therapeutics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-27-2023,MRNA,0.086556,Neutral,-0.026407
"CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023",20230322T232300,https://www.globenewswire.com/news-release/2023/03/22/2632792/37704/en/CytomX-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-on-March-27-2023.html,MRNA,0.092927,Neutral,-0.029116
CytomX Therapeutics to Present at Upcoming March Investor Conferences - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20230228T210500,https://www.benzinga.com/pressreleases/23/02/g31103016/cytomx-therapeutics-to-present-at-upcoming-march-investor-conferences,MRNA,0.082963,Neutral,-0.027199
CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific  ( TCB )  Collaboration with Astellas,20230126T120000,https://www.globenewswire.com/news-release/2023/01/26/2595893/37704/en/CytomX-Therapeutics-Announces-Milestone-Achievement-in-Probody-T-Cell-Engaging-Bispecific-TCB-Collaboration-with-Astellas.html,MRNA,0.034136,Neutral,-0.025463
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference,20230117T210500,https://www.benzinga.com/pressreleases/23/01/g30450762/cytomx-therapeutics-to-present-at-the-b-riley-securities-virtual-annual-oncology-investor-conferen,MRNA,0.07913,Neutral,-0.040319
"5 Most Expensive Health Care Stocks You Should Worry About - Alterity Therapeutics  ( NASDAQ:ATHE ) , Cellectis  ( NASDAQ:CLLS ) ",20230112T140141,https://www.benzinga.com/news/23/01/30389571/5-most-expensive-health-care-stocks-you-should-worry-about,MRNA,0.124164,Neutral,0.0
"Tesla, Moderna And These 2 Stocks Insiders Are Selling - Albemarle  ( NYSE:ALB ) , Hewlett Packard  ( NYSE:HPE ) ",20230109T140336,https://www.benzinga.com/news/23/01/30332910/tesla-moderna-and-these-2-stocks-insiders-are-selling,MRNA,0.407844,Somewhat-Bullish,0.166328
CytomX  ( CTMX )  Up 55% on Strategic Partnership With Moderna,20230106T184600,https://www.zacks.com/stock/news/2036409/cytomx-ctmx-up-55-on-strategic-partnership-with-moderna,MRNA,0.450165,Somewhat-Bullish,0.265246
Why CytomX Therapeutics  ( CTMX )  Shares Are Soaring Today - CytomX Therapeutics  ( NASDAQ:CTMX ) ,20230106T153029,https://www.benzinga.com/general/biotech/23/01/30310896/cytomx-shares-move-higher-on-collaborating-pact-with-this-famed-covid-19-vaccine-maker,MRNA,0.7887,Bullish,0.610894
"Moderna, CytomX to collaborate on mRNA-based therapies",20230105T213200,https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cytomx-announce-mrna-collaboration-2023-01-05/,MRNA,0.552443,Neutral,0.036635
"CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics - CytomX Therapeutics  ( NASDAQ:CTMX ) , Moderna  ( NASDAQ:MRNA ) ",20230105T210500,https://www.benzinga.com/pressreleases/23/01/g30301606/cytomx-and-moderna-announce-strategic-research-collaboration-for-mrna-based-conditionally-activate,MRNA,0.326211,Neutral,0.103769
Can Rigel Pharmaceuticals  ( RIGL )  Beat Q4 Earnings Estimates?,20240219T133400,https://www.zacks.com/stock/news/2227756/can-rigel-pharmaceuticals-rigl-beat-q4-earnings-estimates,MRNA,0.274012,Neutral,-0.093306
"Biotech Stock Roundup: BLUE Up on Regulatory Updates, RIGL's Pipeline News & More",20220615T172600,https://www.zacks.com/stock/news/1939474/biotech-stock-roundup-blue-up-on-regulatory-updates-rigls-pipeline-news-more,MRNA,0.095574,Neutral,-0.146145
"Earnings Scheduled For May 4, 2022",20220504T083630,https://www.benzinga.com/news/earnings/22/05/26983503/earnings-scheduled-for-may-4-2022,MRNA,0.010898,Neutral,-0.001554
